Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa.
Amelie PielenAnima Desiree BühlerSonja Ute HeinzelmannDaniel BöhringerThomas NessBernd JunkerPublished in: Journal of ophthalmology (2017)
Dexamethasone significantly reduced ME secondary to RVO refractory to anti-VEGF. Functional gain was limited compared to treatment naïve eyes, probably due to worse BCVA and CFT at baseline in treatment naïve eyes.